Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence

Journal of Clinical Virology

Volumn 25, Issue 2, 2002, Pages 135-143

  Lehmann, Hartwig W ^a   Kühner, Lucia ^a   Beckenlehner, Karin ^b   Müller Godeffroy, Esther ^c   Heide, Karl Günter ^a   Küster, Rolf Michael ^a   Modrow, Susanne ^b  

^a Rheumaklinik Bad Bramstedt ^*  (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Juvenile arthritis; NS1 protein; Parvovirus B19; Viral persistence

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; STRUCTURAL PROTEIN; VIRUS ANTIBODY; VIRUS DNA; VIRUS PROTEIN;

ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTHRALGIA; ARTICLE; CHILD; DERMATOMYOSITIS; DISEASE COURSE; DISEASE SEVERITY; GENE AMPLIFICATION; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; PARVOVIRUS; PRIORITY JOURNAL; RHEUMATIC DISEASE; SYSTEMIC SCLEROSIS; VIRUS GENOME; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CAPSID; CAPSID PROTEINS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RHEUMATIC DISEASES; SEVERITY OF ILLNESS INDEX; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0036702139     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(01)00247-5     Document Type: Article

References (42)

1. Agbandje-McKenna M., Rossmann M.G. The structure of human parvovirus B19. Anderson L.J., Young N.S., Human Parvovirus B19. Monograph in Virology. 20:1997;3-15 Karger, Basel.
2. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1987;315-323.
3. Brown K.E. Human parvovirus B19 epidemiology and clinical manifestations. Anderson L.J., Young N.S., Human Parvovirus B19. Monograph in Virology. 20:1997;42-60 Karger, Basel.
4. Bullinger M., Mackensen S., Kirchberger I. KINDL-ein Fragebogen zur Erfassung gesundheitsbezogener Lebensqualität von Kindern. Zeitschrift für Gesundheitspsychologie. II:1994;64-77.
5. Cassinotti P., Siegl G. Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual. Eur. J. Clin. Microbiol. Infect. Dis. 19:2000;886-887.
6. Cassinotti P., Burtonboy G., Fopp M., Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J. Med. Virol. 53:1997;229-232.
7. Cassinotti P., Siegl G., Michel B.A., Bruhlmann P. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin. J. Med. Virol. 56:1998;199-204.
8. Cherry J.D. Parvovirus infections in children and adults. Adv. Pediatr. 46:1994;245-269.
9. Chevrel G., Calvet A., Belin V., Miossec P. Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle. Rheumatology. 39:2000;1037-1039.
10. Dorsch S., Kaufmann B., Schaible U., Prohaska E., Wolf H., Modrow S. The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability. J. Gen. Virol. 82:2000;191-199.
11. Eis-Hübinger A.M., Reber U., Abdul-Nour T., Glatzel U., Lauschke H., Putz U. Evidence for persistence of parvovirus B19 DNA in livers of adults. J. Med. Virol. 65:2001;395-401.
12. Faden H., Gary J.G.W., Anderson L.J. Chronic parvovirus infection in a presumably immunologically healthy woman. Clin. Infect. Dis. 15:1992;595-597.
13. Ferri C., Longombardo G., Azzi A., Zakrzewska K. Parvovirus B19 and systemic sclerosis patients. Clin. Exp. Rheumatol. 17:1999;267-268.
14. Gareus R., Gigler A., Hemauer A., Leruez-Ville M., Morinet F., Wolf H., Modrow S. Characterization of cis-acting and NS1-responsive elements in the p6 promoter of parvovirus B19. J. Virol. 72:1998;609-616.
15. Hedman K., Lappalainen M., Söderlund M., Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev. Med. Microbiol. 4:1993;123-129.
16. Hemauer A., von Poblotzki A., Gigler A., Cassinotti P., Siegl G., Wolf H., et al. Sequence variability among different parvovirus B 19 isolates. J. Gen. Virol. 77:1996;1781-1785.
17. Hemauer A., Modrow S., Georgi J., Helmke K., Veith P., Lang B., Schölmerich J., Straub R.H. There is no correlation between polymyalgia rheumatica and acute parvovirus B19 infection. Ann. Rheum. Dis. 58:1999;657.
18. Hemauer A., Gigler A., Searle K., Beckenlehner K., Raab U., Broliden K., et al. Seroprevalence of parvovirus B19 NS1-specific IgG in B19 infected and uninfected individuals and in infected pregnant women. J. Med. Virol. 60:2000;48-55.
19. Jordan J., Tiangco B., Kiss J., Koch W. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcome of transfusion patients. Vox Sang. 75:1998;97-102.
20. Kanski J. Uveitis in: Juvenile chronic arthritis, Clin Exp Rheumatol 1990;499-503.
21. Kerr J.R., Cuniffe V.S. Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection. Rheumatology. 39:2000;903-908.
22. Kurtzman G.J., Ozawa K., Cohen B., Hanson G., Oseas R., Blase R.M., Young N.S. Chronic bone marrow failure due to persistent parvovirus B19 infection. New Engl. J. Med. 317:1987;287-294.
23. Kurtzman G.J., Cohen B., Hanson G., Field A.M., Oseas R., Blase R.M., Young N.S. Immune response to parvovirus B19 and an antibody defect in persistent viral infection. J. Clin. Invest. 84:1989a;1114-1123.
24. Kurtzman G.J., Frickhofen N., Kimball J., Jenkins D.W., Nienhuis A.W., Young N.S. Pure red cell aplasia of 10 years duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. New Engl. J. Med. 321:1989b;519-523.
25. Mimori A., Misaki Y., Hachiya T., Ito K., Kano S. Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis. Rheum. Int. 14:1994;87-90.
26. Moffat S., Yaegashi N., Tada K., Tanaka N., Sugamura K. Human parvovirus B19 nonstructural protein induces apoptosis in erythroid lineage cells. J. Virol. 72:1998;3018-3028.
27. Nigro G., Bastianon V., Colloridi V., Ventriglia F., Gallo P., D'Amati G., Koch W.C., Adler S.P. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of three cases and review. Clin. Infect. Dis. 31:2000;65-69.
28. Ozawa K., Young N. Characterisation of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J. Virol. 62:1987;2508-2511.
29. Petty R.E., Southwood T.R., Baum J., Bheattay E., Glass D.N., Manners P., et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis. J. Rheumatol. 25:1998;1991-1993.
30. Prowse C., Ludlam C.A., Yap P.L. Human parvovirus B19 and blood products. Vox Sang. 72:1997;1-10.
31. Raab U., Bauer B., Gigler A., Beckenlehner K., Wolf H., Modrow S. Cellular transcription factors that interact with p6 promoter elements of parvovirus B19. J. Gen. Virol. 82:2001;1473-1480.
32. Ravens-Sieberer, Bullinger M, Kindl R. Fragebogen zur Erfassung der gesundheitsbezogenen Lebensqualität bei Kindern und Jugendlichen. Revidierte Form, Testmanual, 2000.
33. Schowengerdt K.O., Ni J., Denfield S.W., Gajarski R.J., Bowles N.E., Rosenthal G., Kearney D.L., Price J.K., Rogers B.B., Schauer G.M., Chinnok R.E., Towbin J.A. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation. 96:1997;3549-3554.
34. Singh G., Athreya B.H., Fries J.F., Goldsmith D.P. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 37:1991;1761-1769.
35. Söderlund M., Brown C.S., Cohen B.J., Hedman K. Accurate serodiagnosisof B19 parvovirus infections by measurement of IgG avidity. J. Infect. Dis. 171:1995;710-713.
36. Török T.J. Unusual clinical manifestations reported in patients with parvovirus B19 infection. Anderson L.J., Young N.S., Human Parvovirus B19. Monograph in Virology. 20:1997;61-92 Karger, Basel.
37. Vejlgaard T.B., Nielsen O.B.F. Subacut thyreoiditis ved Parvoviris B19-inkeftion. Ugeskr. Laeg. 156:1994;6039-6040.
38. von Poblotzki A., Gigler A., Lang B., Wolf H., Modrow S. Antibodies to parvovirus B19 NS1 protein in infected individuals. J. Gen. Virol. 76:1995a;519-527.
39. von Poblotzki A., Hemauer A., Gigler A., Puchhammer-Stöckl E., Heinz F.X., Pont J., et al. Antibodies to the non-structural protein of parvovirus in persistently infected patients: implications for pathogenesis. J. Infect. Dis. 172:1995b;1356-1359.
40. Wakamatsu C., Takakura F., Kojima E., Kiriyama Y., Goto N., Matsumoto K., Oyama M., Dato H., Okochi K., Maeda Y. Screening of blood donors for human parvovirus B19 and characterization of the results. Vox Sang. 76:1999;14-23.
41. White D.G., Woolf A.D., Mortimer P.P., Cohen B.J., Blake D.R., Bacon P.A. Human parvovirus arthropathy. Lancet. 1:1985;419-421.
42. Yaegashi N., Niinuma T., Chisaka H., Uehara S., Moffat S., Tada K., et al. Parvovirus B19 infection induces apoptosis of erythroid cells in vitro and in vivo. J. Infect. 39:1999;68-76.